COVID-19 Pill Could Be Available Later This Year: Pfizer CEO
THURSDAY, April 29, 2021 -- A pill to treat COVID-19 is being developed by Pfizer and could be available by the end of the year, company CEO Albert Bourla says.
In March, Pfizer launched an early-stage clinical trial of a new antiviral drug for the coronavirus that causes COVID-19, CBS News reported. The drug reduces the production of enzymes the virus needs to multiply in human cells.
If clinical trials are successful and the U.S. Food and Drug Administration approves the drug, it could be available across the United States later in 2021, Bourla told CNBC on Tuesday, CBS News reported.
Last month, Mikael Dolsten, M.D., chief scientific officer and president, worldwide research, development, and medical of Pfizer, said it is possible that the new drug could be prescribed "at the first sign of infection, without requiring that patients are hospitalized or in critical care."
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
FRIDAY, May 14, 2021 -- Patients hospitalized with COVID-19 may be at risk for developing new heart failure, according to a research letter published in the May 4 issue of the...
THURSDAY, May 13, 2021 -- The U.S. Centers for Disease Control and Prevention said Wednesday that COVID-19 vaccines can be given along with other childhood shots, CNN reported...
THURSDAY, May 13, 2021 -- Fully vaccinated Americans can now skip face masks and social distancing in most indoor or outdoor settings, the U.S. Centers for Disease Control and...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.